Anavex Life Sciences Corp. (LON:0HFR)
London flag London · Delayed Price · Currency is GBP · Price in USD
11.08
+0.03 (0.27%)
At close: Jul 11, 2025

Anavex Life Sciences Statistics

Total Valuation

LON:0HFR has a market cap or net worth of GBP 692.88 million. The enterprise value is 606.44 million.

Market Cap692.88M
Enterprise Value 606.44M

Important Dates

The next estimated earnings date is Tuesday, August 12, 2025.

Earnings Date Aug 12, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class 85.37M
Shares Outstanding n/a
Shares Change (YoY) +3.60%
Shares Change (QoQ) +0.32%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 82.53M

Valuation Ratios

PE Ratio n/a
Forward PE 11.45
PS Ratio n/a
PB Ratio 8.97
P/TBV Ratio 8.97
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -16.62
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 6.74

Current Ratio 6.74
Quick Ratio 6.70
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -40.17% and return on invested capital (ROIC) is -28.36%.

Return on Equity (ROE) -40.17%
Return on Assets (ROA) -25.44%
Return on Invested Capital (ROIC) -28.36%
Return on Capital Employed (ROCE) -53.37%
Revenue Per Employee n/a
Profits Per Employee -868,730
Employee Count42
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +108.00% in the last 52 weeks. The beta is 0.67, so LON:0HFR's price volatility has been lower than the market average.

Beta (5Y) 0.67
52-Week Price Change +108.00%
50-Day Moving Average 8.82
200-Day Moving Average 8.58
Relative Strength Index (RSI) 65.05
Average Volume (20 Days) 4,107

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 28.28

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -41.21M
Pretax Income -36.49M
Net Income -36.49M
EBITDA n/a
EBIT -41.21M
Earnings Per Share (EPS) -0.43
Full Income Statement

Balance Sheet

The company has 89.61 million in cash and n/a in debt, giving a net cash position of 89.61 million.

Cash & Cash Equivalents 89.61M
Total Debt n/a
Net Cash 89.61M
Net Cash Per Share n/a
Equity (Book Value) 77.21M
Book Value Per Share 0.90
Working Capital 77.21M
Full Balance Sheet

Cash Flow

Operating Cash Flow -23.08M
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

LON:0HFR does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -3.60%
Shareholder Yield n/a
Earnings Yield -5.27%
FCF Yield n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1